Rachel K. King Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Rachel K. King.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Rachel K. King. Rachel K. King is a Director in NOVAVAX INC ($NVAX) and a President, CEO in GLYCOMIMETICS INC ($GLYC).

Address: C/O GLYCOMIMETICS, INC. 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG 20879 MD

Companies in which Rachel K. King is an Insider

GLYCOMIMETICS INC

Trading Symbol: GLYC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Rachel K. King: President, CEO
Holdings: 452,314 shares
Current Value: $2,831,486
Latest Transaction: Jan 22 2021
$GLYC Market Capitalization: $140.70M
$GLYC Previous Close: $6.26

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

NOVAVAX INC

Trading Symbol: NVAX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Rachel K. King: Director
Holdings: 42,000 shares
Current Value: $55,020
Latest Transaction: Jun 26 2020
$NVAX Market Capitalization: $355.26M
$NVAX Previous Close: $1.31

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Rachel K. King

Sentiment: All, GLYC, NVAX

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 22 2021GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseA3.81192,500733,425192,500
Jan 22 2021GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOGrantA0.0096,2500452,314356.1 K to 452.3 K (+27.03 %)
Dec 30 2020GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseM1.12130,821146,5200
Dec 30 2020GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOSellS3.9184,176329,128356,064440.2 K to 356.1 K (-19.12 %)
Dec 30 2020GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOBuyM1.12130,821146,520440,240309.4 K to 440.2 K (+42.28 %)
Jun 26 2020NVAXNOVAVAX INCKing Rachel K.DirectorOption ExerciseA0.003,45003,450
Jun 26 2020NVAXNOVAVAX INCKing Rachel K.DirectorOption ExerciseA83.546,900576,4266,900

View all Rachel K. King insider transactions.